Evolus Future Growth
Future criteria checks 5/6
Evolus is forecast to grow earnings and revenue by 73.9% and 24.3% per annum respectively while EPS is expected to grow by 73.5% per annum.
Key information
73.9%
Earnings growth rate
73.5%
EPS growth rate
| Pharmaceuticals earnings growth | 19.6% |
| Revenue growth rate | 24.3% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 07 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 461 | 17 | 47 | 80 | 6 |
| 12/31/2025 | 349 | -25 | -10 | 16 | 6 |
| 12/31/2024 | 264 | -49 | -15 | 9 | 6 |
| 9/30/2024 | 248 | -55 | -26 | -22 | N/A |
| 6/30/2024 | 237 | -53 | -20 | -17 | N/A |
| 3/31/2024 | 220 | -60 | -26 | -24 | N/A |
| 12/31/2023 | 202 | -62 | -36 | -34 | N/A |
| 9/30/2023 | 185 | -63 | -46 | -44 | N/A |
| 6/30/2023 | 169 | -66 | -63 | -60 | N/A |
| 3/31/2023 | 156 | -72 | -70 | -67 | N/A |
| 12/31/2022 | 149 | -74 | -88 | -85 | N/A |
| 9/30/2022 | 140 | -79 | -87 | -85 | N/A |
| 6/30/2022 | 132 | -79 | -101 | -100 | N/A |
| 3/31/2022 | 121 | -71 | -64 | -63 | N/A |
| 12/31/2021 | 100 | -47 | -34 | -33 | N/A |
| 9/30/2021 | 86 | -139 | -27 | -27 | N/A |
| 6/30/2021 | 77 | -131 | -10 | -8 | N/A |
| 3/31/2021 | 58 | -137 | -40 | -38 | N/A |
| 12/31/2020 | 57 | -163 | -61 | -58 | N/A |
| 9/30/2020 | 55 | -67 | -76 | -72 | N/A |
| 6/30/2020 | 51 | -82 | -87 | -83 | N/A |
| 3/31/2020 | 45 | -99 | -107 | -102 | N/A |
| 12/31/2019 | 35 | -90 | -98 | -93 | N/A |
| 9/30/2019 | 15 | -88 | -93 | -89 | N/A |
| 6/30/2019 | 2 | -73 | -73 | -70 | N/A |
| 3/31/2019 | N/A | -52 | -43 | -43 | N/A |
| 12/31/2018 | N/A | -47 | -26 | -26 | N/A |
| 9/30/2018 | N/A | -30 | -15 | -15 | N/A |
| 6/30/2018 | N/A | -21 | N/A | -12 | N/A |
| 3/31/2018 | N/A | -7 | N/A | -10 | N/A |
| 12/31/2017 | N/A | -4 | N/A | -13 | N/A |
| 9/30/2017 | N/A | -13 | N/A | -14 | N/A |
| 6/30/2017 | N/A | -14 | N/A | -13 | N/A |
| 3/31/2017 | N/A | -18 | N/A | -14 | N/A |
| 12/31/2016 | N/A | -20 | N/A | -13 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0K16 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.1%).
Earnings vs Market: 0K16 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 0K16 is expected to become profitable in the next 3 years.
Revenue vs Market: 0K16's revenue (24.3% per year) is forecast to grow faster than the UK market (3.6% per year).
High Growth Revenue: 0K16's revenue (24.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 0K16's Return on Equity is forecast to be high in 3 years time